Stock Research for VSTM

VSTM

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

VSTM Stock Chart & Research Data

The VSTM chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the VSTM chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


VSTM Due diligence Resources & Stock Charts

The VSTM stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View VSTM Detailed Price Forecast - CNN Money CNN View VSTM Detailed Summary - Google Finance
Yahoo View VSTM Detailed Summary - Yahoo! Finance Zacks View VSTM Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View VSTM Trends & Analysis - Trade-Ideas Barrons View VSTM Major Holders - Barrons
NASDAQ View VSTM Call Transcripts - NASDAQ Seeking View VSTM Breaking News & Analysis - Seeking Alpha
Spotlight View VSTM Annual Report - CompanySpotlight.com OTC Report View VSTM OTC Short Report - OTCShortReport.com
TradeKing View VSTM Fundamentals - TradeKing Charts View VSTM SEC Filings - Bar Chart
WSJ View Historical Prices for VSTM - The WSJ Morningstar View Performance/Total Return for VSTM - Morningstar
MarketWatch View the Analyst Estimates for VSTM - MarketWatch CNBC View the Earnings History for VSTM - CNBC
StockMarketWatch View the VSTM Earnings - StockMarketWatch MacroAxis View VSTM Buy or Sell Recommendations - MacroAxis
Bullish View the VSTM Bullish Patterns - American Bulls Short Pains View VSTM Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View VSTM Stock Mentions - StockTwits PennyStocks View VSTM Stock Mentions - PennyStockTweets
Twitter View VSTM Stock Mentions - Twitter Invest Hub View VSTM Investment Forum News - Investor Hub
Yahoo View VSTM Stock Mentions - Yahoo! Message Board Seeking Alpha View VSTM Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for VSTM - SECform4.com Insider Cow View Insider Transactions for VSTM - Insider Cow
CNBC View VSTM Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for VSTM - OTC Markets
Yahoo View Insider Transactions for VSTM - Yahoo! Finance NASDAQ View Institutional Holdings for VSTM - NASDAQ


Stock Charts

FinViz View VSTM Stock Insight & Charts - FinViz.com StockCharts View VSTM Investment Charts - StockCharts.com
BarChart View VSTM Stock Overview & Charts - BarChart Trading View View VSTM User Generated Charts - Trading View


Latest Financial News for VSTM

Verastem to Host Analyst and Investor Day on May 2, 2018
Posted on Monday April 23, 2018

Verastem, Inc. , focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients, today announced that it will host an Analyst and Investor Day titled, “Duvelisib: Harnessing the Power of Dual PI3K Inhibition,” on Wednesday, May 2, 2018 from 10:30 am – 1:00 pm ET in New York City.


Analysis: Positioning to Benefit within Verastem, DineEquity, Olin, Quantum, Kimco Realty, and NovoCure — Research Highlights Growth, Revenue, and Consolidated Results
Posted on Thursday April 19, 2018

NEW YORK, April 19, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...


Verastem (VSTM) in Focus: Stock Moves 8% Higher
Posted on Friday April 13, 2018

Shares of Verastem (VSTM) rose nearly 8% yesterday.


Verastem Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted on Monday April 09, 2018

Verastem, Inc. , focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients, today announced the grant of stock options to six new employees to purchase an aggregate of 364,000 shares of Verastem’s common stock.


Enter a stock symbol to view the stock details.